Dr. Reddy's Laboratories Faces Market Challenges Amid Valuation Discrepancies and Mixed Performance
Dr. Reddy's Laboratories has shown mixed stock performance amid a challenging market, maintaining its opening price of Rs 1261.3. With a market capitalization of Rs 1,04,239.26 crore and a P/E ratio significantly below the industry average, the company has experienced a year-over-year decline while demonstrating resilience over three years.
Dr. Reddy's Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced notable activity today, reflecting a complex market environment. The stock opened at Rs 1261.3 and has maintained this price throughout the trading session. However, it has underperformed the sector by 0.44%, marking a decline of 3.13% over the last three days.In terms of financial metrics, Dr. Reddy's Laboratories holds a market capitalization of Rs 1,04,239.26 crore and a price-to-earnings (P/E) ratio of 18.67, significantly lower than the industry average of 36.57. This indicates a potential valuation gap compared to its peers.
The stock's performance over various time frames reveals a mixed picture. Over the past year, it has declined by 9.42%, while the Sensex has only seen a minor drop of 1.03%. In contrast, the stock has shown resilience over the three-year period, with a robust gain of 51.88%, outperforming the Sensex's 39.41% increase.
Overall, Dr. Reddy's Laboratories continues to navigate a challenging market landscape, with its recent performance reflecting broader industry trends.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
